Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Groleau, Melanie. Insider active across 1 company, notably Knight Therapeutics Inc.. Cumulatively, 18 disclosures have been logged. Split: 6 buys · 0 sell. Total volume traded: €280k. Activity tracked since 10 June 2026. The latest transaction was filed on 10 June 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. All data is free.
Companies and markets linked to Groleau, Melanie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4,390 shares@ CA$6.210.0019% mcap2.4% of flowOptionsTSXSEDI:4733752
18 of 18 declarations
About Groleau, Melanie
Melanie Groleau is a declarant linked to Knight Therapeutics Inc. (XTSE) as 5 - Senior Officer of Issuer. The 18 filings on record, all within the recent sample, are dated 2026-06-10, with EUR 279842 of buys and EUR 0 of sells, and the most common transaction nature is 51 - Exercise of options.